Immunology
-
A pair of non-competing neutralizing human monoclonal antibodies protecting from disease in a SARS-CoV-2 infection model
This article has 33 authors:Reviewed by ScreenIT
-
CoVac501, a self-adjuvanting peptide vaccine conjugated with TLR7 agonists, against SARS-CoV-2 induces protective immunity
This article has 38 authors:Reviewed by ScreenIT
-
An mRNA SARS-CoV-2 Vaccine Employing Charge-Altering Releasable Transporters with a TLR-9 Agonist Induces Neutralizing Antibodies and T Cell Memory
This article has 11 authors:Reviewed by ScreenIT
-
Pre-existing T cell-mediated cross-reactivity to SARS-CoV-2 cannot solely be explained by prior exposure to endemic human coronaviruses
This article has 6 authors:Reviewed by ScreenIT
-
Cross-neutralization of SARS-CoV-2 by a human monoclonal SARS-CoV antibody
This article has 25 authors:Reviewed by ScreenIT
-
A spike-ferritin nanoparticle vaccine induces robust innate immune activity and drives polyfunctional SARS-CoV-2-specific T cells
This article has 17 authors:Reviewed by ScreenIT
-
Celastrol: A lead compound that inhibits SARS‐CoV‐2 replication, the activity of viral and human cysteine proteases, and virus‐induced IL‐6 secretion
This article has 15 authors:Reviewed by ScreenIT
-
Immunological memory to SARS-CoV-2 assessed for up to eight months after infection
This article has 21 authors:Reviewed by Rapid Reviews Infectious Diseases, ScreenIT
-
SARS-CoV-2–associated ssRNAs activate inflammation and immunity via TLR7/8
This article has 17 authors:Reviewed by ScreenIT
-
An autoantigen profile of human A549 lung cells reveals viral and host etiologic molecular attributes of autoimmunity in COVID-19
This article has 5 authors:Reviewed by ScreenIT